Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021

SELL
$33.54 - $40.55 $25,993 - $31,426
-775 Closed
0 $0
Q1 2021

Apr 20, 2021

SELL
$42.51 - $63.78 $12,753 - $19,134
-300 Reduced 27.91%
775 $35,000
Q2 2020

Jul 27, 2020

SELL
$46.85 - $61.05 $20,379 - $26,556
-435 Reduced 28.81%
1,075 $63,000
Q4 2019

Jan 29, 2020

BUY
$53.85 - $65.27 $81,313 - $98,557
1,510 New
1,510 $91,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track S.A. Mason LLC Portfolio

Follow S.A. Mason LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S.A. Mason LLC, based on Form 13F filings with the SEC.

News

Stay updated on S.A. Mason LLC with notifications on news.